BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29335408)

  • 1. Escape from thymic deletion and anti-leukemic effects of T cells specific for hematopoietic cell-restricted antigen.
    Ju JM; Jung MH; Nam G; Kim W; Oh S; Kim HD; Kim JY; Chang J; Lee SH; Park GS; Min CK; Lee DS; Kim MG; Choi K; Choi EY
    Nat Commun; 2018 Jan; 9(1):225. PubMed ID: 29335408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.
    Choi EY; Choi K; Nam G; Kim W; Chung M
    Front Immunol; 2020; 11():1163. PubMed ID: 32587590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.
    Yoo KI; Jeon JY; Ryu SJ; Nam G; Youn H; Choi EY
    Exp Mol Med; 2015 Feb; 47(2):e140. PubMed ID: 25676063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.
    Bosco N; Swee LK; Bénard A; Ceredig R; Rolink A
    Exp Hematol; 2010 Mar; 38(3):222-232.e2. PubMed ID: 20045443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
    Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
    J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized Mice Reveal New Insights Into the Thymic Selection of Human Autoreactive CD8
    Li Y; Teteloshvili N; Tan S; Rao S; Han A; Yang YG; Creusot RJ
    Front Immunol; 2019; 10():63. PubMed ID: 30778347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor antigen h60-mediated aplastic anemia is ameliorated by immunosuppression and the infusion of regulatory T cells.
    Chen J; Ellison FM; Eckhaus MA; Smith AL; Keyvanfar K; Calado RT; Young NS
    J Immunol; 2007 Apr; 178(7):4159-68. PubMed ID: 17371972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR diversity of H60-specific CD8 T cells during the response evolution and influence of CD4 help.
    Choi JH; Ryu SJ; Jung KM; Kim S; Chang J; Kim TW; Choi EY
    Transplantation; 2009 Jun; 87(11):1609-16. PubMed ID: 19502951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S; Baron C; Hétu F; Roy DC; Perreault C
    J Immunol; 1995 Dec; 155(11):5104-14. PubMed ID: 7594519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human invariant chain isoform p35 restores thymic selection and antigen presentation in CD74-deficient mice.
    Genève L; Chemali M; Desjardins M; Labrecque N; Thibodeau J
    Immunol Cell Biol; 2012 Oct; 90(9):896-902. PubMed ID: 22689013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-positive thymocytes select mucosal-associated invariant T cells.
    Seach N; Guerri L; Le Bourhis L; Mburu Y; Cui Y; Bessoles S; Soudais C; Lantz O
    J Immunol; 2013 Dec; 191(12):6002-9. PubMed ID: 24244014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells.
    Garg G; Nikolouli E; Hardtke-Wolenski M; Toker A; Ohkura N; Beckstette M; Miyao T; Geffers R; Floess S; Gerdes N; Lutgens E; Osterloh A; Hori S; Sakaguchi S; Jaeckel E; Huehn J
    Oncotarget; 2017 May; 8(22):35542-35557. PubMed ID: 28415767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of Thymocytes Expressing Transgenic TCR Specific for a Minor Histocompatibility Antigen, H60.
    Ju JM; Kim MB; Ryu SJ; Kim JY; Chang J; Choi EY
    Immune Netw; 2015 Oct; 15(5):222-31. PubMed ID: 26557806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limiting TCR expression leads to quantitative but not qualitative changes in thymic selection.
    Dave VP; Allman D; Wiest DL; Kappes DJ
    J Immunol; 1999 May; 162(10):5764-74. PubMed ID: 10229809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo T-lymphocyte tolerance in the absence of thymic clonal deletion mediated by hematopoietic cells.
    van Meerwijk JP; MacDonald HR
    Blood; 1999 Jun; 93(11):3856-62. PubMed ID: 10339493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell differentiation/maturation of CD34+ stem cells from HIV-seropositive hemophiliacs in cultured thymic epithelial fragments.
    Ruiz M; Roodman ST; Bouhasin JD; Knutsen AP
    Stem Cells; 1996 Jan; 14(1):132-45. PubMed ID: 8820959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell exhaustion and a failure in antigen presentation drive resistance to the graft-versus-leukemia effect.
    Zhou M; Sacirbegovic F; Zhao K; Rosenberger S; Shlomchik WD
    Nat Commun; 2020 Aug; 11(1):4227. PubMed ID: 32839441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.